Biodiversity and Human Health Biodiversity and Human Health   Field researcher inspects a deer mouse for signs of hantavirus

AGENTS OF BIOTERRORISM: BOTULINUM TOXIN
by Joseph Dougherty

The toxin that causes botulism is quite probably the single most potent poison on this planet. This page describes its symptoms and prevention.

Topics:

 

Description

Botulism is a paralytic neuromuscular disorder caused by the toxin of a bacterium, Clostridium botulinum.

Clostridium botulinum

Clostridium botulinum is a ubiquitous gram-positive, spore forming, obligate anaerobe found in soil and marine environments throughout the world. In the United States, food-borne botulism has been associated primarily with home canned foods, particularly vegetables, fruit, and condiments, and less commonly with meats and fish. There are seven distinct types of the toxin, but human poisoning is usually caused by Type A, B, E, or F. Type E outbreaks are frequently associated with fish products. Although uncommon, the spores can be aerosolized by soil tilling, road work, or dust storms.

Naturally occurring botulism is the disease that results from the absorption of botulinum toxin into the circulation from a mucosal surface (usually the gut in adults and the lung in infants) or a wound. The toxin does not penetrate intact skin and does not cross the blood-brain barrier. The toxin irreversibly blocks the peripheral cholinergic synapses throughout the body, most importantly at the neuromuscular junction. This blockage prevents the release of the neurotransmitter acetylcholine from the terminal end of motor neurons. This leads to muscle paralysis, including the diaphragm, and in severe cases can lead to the need for mechanical respiration to prevent a patient's suffocation.

Bioterrorism

Botulinum toxin poses a major bioweapons threat because of its extreme potency and lethality. Prolonged intensive care is often necessary for affected persons. Botulinum toxin is probably the single most poisonous substance known to man -- extremely small quantities can have lethal results. Because toxin-containing foods may place others who eat them at risk, and because of the potential use of botulinum toxin as a biological weapon, public health officials consider any case of botulism to be a significant event and all cases should be reported immediately to state and local public health officials.

Three Manifestations of Botulism

The bacterial toxin typically acts in the intestine (an enterotoxin) and causes systemic poisoning. There are three generally recognized types of botulism: foodborne, wound, and infantile:

  • Foodborne botulism (the most common form) occurs when C. botulinum toxin (present in contaminated foods, such an improperly prepared or inadequately stored homemade preserves) is ingested. Foods with dairy products left unrefrigerated for extended periods are a common risk (the infamous egg salad or potato salad at summer picnics). Many types of food have been implicated in outbreaks in the past, with the most common factor being that these items were inadequately heated (temperatures greater than 85°C inactivate the toxin, but the spores may persist up to ) during preparation or were left unrefrigerated for an extended period after preparation. The largest botulism outbreak in the U.S. in the past century occurred in 1977, when 59 people became ill from poorly preserved jalapeño peppers.
  • Wound botulism is caused from C. botulinum toxin produced in wounds that are contaminated with the bacterium, which exists naturally in many soils. Thus, dirty wounds that are not adequately disinfected run the risk of culturing C. botulinum. Wound botulism is becoming more common, with the increase largely attributable to heroin users who inject the drug subcutaneously.
  • Infant botulism typically affects previously well infants within the first 4 to 6 months of life (median=10 weeks) and is caused by ingestion of C. botulinum spores that germinate and produce toxins in the GI tract. Although there are seven antigenically distinct types of botulinum toxins, all known cases of infant botulism have been caused by types A or B. Honey and corn syrup both pose risks for infant botulism and neither should be given to young children. The clinical spectrum ranges from asymptomatic “carriage” of infant botulism to a fulminant form of the disease that may mimic sudden infant death syndrome (SIDS). Some clinicians postulate that breast-fed infants with botulism are identified in time to save the child because they have a milder disease with later onset, while non breast-fed infants present earlier with a clinical picture identical to that of sudden infant death syndrome.

Frequency of Botulism

In 1999, 173 cases of botulism were reported from 34 states in the United States, of which 26 were foodborne, 106 were infant botulism, and 41 were wound botulism. Between 1976 and 1984, there were 124 outbreaks of food-borne reported to Centers for Disease Control (CDC).

 

Symptoms and Diagnosis

The onset of botulism generally occurs twelve to thirty-six hours after the toxin is ingested. However, the incubation period may vary from a few hours to several days. Symptoms can range from mild to severe. Constipation is characteristically an early sign, reflecting formation of toxin within the GI tract, although this is frequently overlooked. There is a specialized test to detect toxin in serum by bioassay; however, this may be negative, particularly in wound and infant botulism. Therefore, tests that confirm the presence of the organism or its toxin in wounds, vomitus, gastric fluid, or stool are much more effective.

Foodborne Botulism

Cranial nerve involvement often marks the onset of symptoms of foodborne botulism. Symptoms may include dizziness, fatigue, headache, and the feeling of being agitated and/or anxious. The affected individual's mental status remains unaffected. Fever is usually minimal and may, in fact, be absent (afebrile). Affected individuals may experience generalized muscle weakness, often progressing rapidly from the head to involve the neck, arms, chest, and legs. The weakness is usually not the same on both sides of the body (asymmetric). Individuals may also experience nausea, vomiting, severe constipation or diarrhea, and/or urinary retention. Abdominal pain may precede or follow the onset of paralysis. Botulism may also produce progressive muscular paralysis possibly abdominal distention characterized by the absence of normal intestinal sounds. Paralytic obstruction of the intestines (ileus) may also occur.

Eye symptoms may include double vision (diplopia) and/or blurred vision, impaired functioning of the muscles of the eyes (ophthalmoplegia), droopy eyelids (ptosis), an abnormal intolerance of light (photophobia), dilation of the pupil (mydriasis), and an involuntary rapid movement of the eyeball (nystagmus).

Some individuals have difficulty speaking (dysphonia) or slurred speech (dysarthria). Symptoms may also include difficulty in swallowing (dysphagia), a dry mouth and very dry or sore throat. The gag reflex may be suppressed. Some individuals have a tongue that is swollen and "coated."

Weakening of the reflexes (hyporeflexia) may also be present. Pupillary reflexes may be depressed and deep tendon reflexes may be normal or decreased. Some individuals experience a sudden drop in blood pressure upon arising from a bed or chair (postural hypotension) or a rapid heartbeat (tachycardia). Difficulty breathing, irregular rate of respiration, and breathing characterized by rhythmic waxing and waning of the depth of respirations, which may be accompanied by periods of apnea (Cheyne-Stokes respiration), may also be present.

Wound Botulism

Wound botulism is characterized by the same neurological symptoms as foodborne botulism. However, the affected individual experiences no gastrointestinal symptoms nor is there any evidence implicating food as the cause. The skin must be carefully checked for wounds. Wound botulism is common after traumatic injury involving contamination with soil, after cesarean delivery, and in individuals with a chronic substance abuse problem. A fever due to infection from other bacteria may be present.

Infant Botulism

Infant botulism may occur in infants less than 12 months of age. Constipation is initially present in approximately two-thirds of these cases, followed by neuromuscular paralysis. The severity of the disease varies among affected infants. Affected individuals generally have been exposed to foods other than milk contaminated with spores which are common in the environment. Cases have been related to the ingestion of honey, vacuum cleaner dust, and soil that contains C. botulinum.

The differential diagnosis of infant botulism includes other causes of paralysis such as Guillan-Barré syndrome (symmetric ascending paralysis with an elevated CSF protein), poliomyelitits (asymmetric paralysis, fever, and CSF pleocytosis), and myasthenia gravis (muscle fatigability with reversal or ptosis with tensilon). In addition, bacterial sepsis and meningitis must always be excluded in any infant presenting with fever, lethargy, and poor feeding. The absence of a gag reflex, profound hypotonia, and hyporeflexia help to differentiate infant botulism from bacterial sepsis. EMG (if abnormal) typically show a pattern of brief duration, small-amplitude potentials with a decremental response at low repetitive (3-10Hz) stimulation and an incremental or “staircase” response at high repetitive stimulation.

The diagnosis is confirmed by the detection of the organism or its toxin in the infant’s stool. Toxin isolation and identification are accomplished via mouse lethality testing, with typing confirmed by neutralization of the toxin by specific sera.

Similar Paralytic Disorders

Symptoms of the following disorders can be similar to those of botulism. Comparisons may be useful for a differential diagnosis.

  • Eaton-Lambert Syndrome is a neuromuscular disorder that may be an autoimmune disease. Major symptoms include muscle weakness and fatigue especially of the pelvic and thigh muscles. Other symptoms may include dryness of the mouth, impotence, pain in the thighs, and a pricking, tingling or creeping sensation on the skin (paresthesias) around the affected areas.
  • Guillain-Barre Syndrome (acute idiopathic polyneuritis) is a very rare, rapidly progressive disorder causing inflammation of the nerves (polyneuritis) and paralysis. Although the precise cause of Guillain-Barre Syndrome is unknown, a viral or respiratory infection precedes the onset of the syndrome in about half of the cases. This has led to the theory that Guillain-Barre Syndrome may be an autoimmune disease (caused by the body's own immune system). Damage to the covering of nerve cells (myelin) and nerve axons (the extension of the nerve cell that conducts impulses away from the nerve cell body) results in delayed nerve signal transmission. There is a corresponding weakness in the muscles that are supplied with nerve impulses (innervated) by the affected nerves.
  • Myasthenia Gravis is a chronic neuromuscular disease characterized by weakness and abnormally rapid fatigue of muscles, particularly those that are controlled by the brain stem (bulbar-innervated). The symptoms of Myasthenia Gravis typically improve following a period of rest. Any muscle may be affected by this disorder. However, the muscles around the eyes (extraocular) and those used in swallowing are most frequently affected by Myasthenia Gravis.

Prevention

It is essential that both home canned and commercially canned foods be prepared properly. To prevent botulism, these foods must be adequately heated before serving. Food that shows any sign of spoilage should be discarded. Unabsorbed toxin may be eliminated by induction of vomiting, gastric lavage, and purgation.

Clostridium botulinum spores are highly resistant to heat and may survive for several hours at tempatures of 100°C. Exposure to moist heat at 120° centigrade kills the spores. On the other hand, the toxins are readily destroyed by heat. Therefore cooking food at 80°C for 30 minutes protects against botulism. While home-canned food is the most common source for botulism, commercially prepared foods have been implicated in about ten percent of the cases. Vegetables, fish, fruits and condiments are the most commonly involved; however beef, dairy products, pork, poultry, and other foods have also been implicated. To reduce the risk of infant botulism it is recommended that honey not be fed to infants who are less than 12 months of age.

Medical Treatment

Since respiratory impairment and its complications may be life threatening, affected individuals should be hospitalized and closely supervised. Prolonged artificial respiration may be required.

Adult Care

Antibiotic therapy is not indicated for the treatment of foodborne or infant botulism. For wound botulism, antibiotic therapy may include agents such as penicillin G or metronidazole. Intravenous equine (made from horses) antitoxin, administered as early as possible in the course of illness, is the only specific treatment available for foodborne and wound botulism. Equine antitoxin can be toxic to babies with infantile botulism, however, so human botulism immune globuline is prepared for infants. Antitoxin will not reverse established neurological damage, but may prevent the progression of disease, shorten the duration of ventilatory failure, and reduce the period of hospitalization.

Trivalent antitoxin (A, B, E) is available on a 24-hour basis from the Centers for Disease Control in Atlanta, GA. They also supply a polyvalent antitoxin for specific outbreaks that are due to Types C, D, or F botulism. Treatment should be initiated as soon as possible. However, the risks of treatment must be weighed against potential benefits. The antitoxins are made from horse serum and there is the possibility, in some individuals, of anaphylaxis or serum sickness. It may even be beneficial to begin treatment even several weeks after ingestion of the toxin. While the use of antitoxin does not reverse preexisting neurological impairment or the binding of already bound toxin, it may possibly slow and halt further progression of the disease.

Infant Care

Aggressive respiratory and nutritional care (nasojejunal tube) are the mainstays of treatment. Many infants require intubation and prolonged mechanical ventilation. Continuous nasogastric feedings are preferred over bolus feedings to minimize the risk of aspiration. Small volumes increased over a few days are well tolerated and decrease the need for central hyperalimentation. Physical and occupational therapies are crucial in maintaining range of motion and functional positioning in patients. Antibiotics have not shown to ameliorate the course of the disease. Aminoglycosides such as gentamicin should be avoided for they may potentiate the neuromuscular blockade. The role of human botulism immune globulin to modify the course of the disease if administered early is being explored.

Prognosis for complete recovery is excellent with meticulous supportive care. Infant botulism is a self-limited disease lasting a total of 2 to 6 weeks with progressive symptoms for 1 to 2 weeks followed by gradual recovery of motor function over 3-4 weeks, as a result of the production of new nerve terminals and motor-end plates. Relapse has been reported after apparent recovery, thus necessitating close supervision and follow-up. It is universally recommended that honey and corn syrup not be fed to infants less than 1 year old to prevent the occurrence of infant botulism.

Investigational Therapies

Guanidine has been used in the treatment of some patients affected with botulism. However, reported results have been inconclusive and thus far the effectiveness of the drug remains unproven. More studies are needed to determine the long-term safety and effectiveness of this medication for the treatment of botulism.

Equine antitoxin is administered to individuals with wound botulism. The wound should be thoroughly explored and cleaned. An antibiotic, such as penicillin, should be given to eradicate C. botulinum from the site, even though the benefit of this therapy is unproven. The wound should be cultured and the results should help guide the use of other antibiotics. Metronidazole may be an effective alternative to penicillin.

There is an experimental botulism vaccine for laboratory workers.

 

Additional Resources

Center for Civilian Biodefense Strategies at Johns Hopkins University
Discussion of Botulinum Toxin and Fact Sheet

NIH/National Institute of Allergy and Infectious Diseases
9000 Rockville Pike
Bethesda MD 20892
3014965717

Centers for Disease Control and Prevention
1600 Clifton Road NE
Atlanta, GA 30333
Telephone: (404) 639-3534

Food and Drug Administration (FDA)
Office of Inquiry and Consumer Information
5600 Fisher Lane
Room 12-A-40
Rockville, MD 20857
Telephone: (301) 827-4420
Toll Free: (888) 463-6332

 

References

TEXTBOOKS

Bartlett JG. Botulism. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine. 20th ed. Philadelphia, PA: W.B. Saunders Co; 1996:1635-36.

Abrutyn E. Botulism. In: Fauci AS, et al., eds. Harrison's Principles of Internal Medicine, 14th Ed. New York, NY: McGraw-Hill, Inc; 1998:904-05.

Berkow R, ed. The Merck Manual-Home Edition. Whitehouse Station, NJ: Merck Research Laboratories; 1997:516-18.

Beers MH, Berkow R, eds. The Merck Manual, 17th ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999:287-89

Bleck TP. Clostridium Botulinum. In: Mandell GL, et al., eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone Inc; 1995:2178-82.

REVIEW ARTICLES

Krishna S, et al. Infant botulism: case reports and review. J Ky Med Assoc. 2001;99:143-46.

Muensterer OJ. Infant botulism. Pediatr Rev. 2000;21:427.

Byrne MP, et al. Development of vaccines for the prevention of botulism. Biochemie. 2000;82:955-66.

JOURNAL ARTICLES

Klein AW. Complications and adverse reactions with the use of botulinum toxin. Semin Cutan med Surg. 2001;20:109-20.

Arnon SS, et al. Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059-70.

Kakinuma H, et al. Application of nested polymerase chain reaction for the rapid diagnosis of infant botulism type b. Acta Paediatr Jpn. 1997; 39:346-48.

Yamakawa K. Emergence of clostridium botulinum type b-like nontoxigenic organisms in a patient with type b infant botulism. J. Clin Microbiol. 1997; 35:2163-64.

Maselli RA. Cluster of wound botulism in california:clinical, electrophysiologic, and pathologic study. Muscle Nerve. 1997; 20:1284-95.

Zouari N, et al. Importance of electromyography in the diagnosis of botulism. Neurophysiol Clin. 1997;27:220-26.

Angelo FJ, et al. A large outbreak of botulism: the hazardous baked potato. J Infect Dis. 1998;178:172-77.

 

Click the banner above to return to the index page.

 

If at any time this site is slow, try using the mirror site:

Pages in this site are formatted to print on 8.5x11 paper directly from your Web browser.


Text and images used by permission are the sole property of their respective authors or other copyright holders,
as indicated, and may not be reproduced without permission unless they are in the public domain.
All other text and images copyright © 2000-2002 Joseph Dougherty.
Send questions/comments to josephd@ecology.org